Dermatology segment

CARA

Cara Therapeutics, Inc. - Common Stock

-7% down -2.69% -4.31

+ Medicine, Disease: Kidney, Disease: Liver, Skin, Dermatology

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.